Catalyst Wire Dossier Catalyst Wire Dossier

UMEC/VI

umeclidinium / vilanterol · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for UMEC/VI, covering 2018-10-10 to 2018-10-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]

See pricing